Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone

<div>Immunohistochemical staining of bone marrow before R-THPCOP. (a) May Grunwald–Giemsa staining (×1000). (b) CD20 (×40). (c) IgA chain (×40). (d) IgM chain (×40). (e) CD138 (×40). Black arrow: lymphoma cell; white arrow: normal-sized plasma cell; double arrow: large-sized plasma cell.</div>

Case Reports in Hematology

fig4

Figure 4

Figure 4: Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 

Figure 4 | Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone 